Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
…, M El-Sayed, C Estes, O Etzion, E Farag… - The Lancet …, 2023 - thelancet.com
Background The 2016 World Health Assembly endorsed the elimination of hepatitis B virus (HBV)
infection as a public health threat by 2030; existing therapies and prophylaxis …
infection as a public health threat by 2030; existing therapies and prophylaxis …
[HTML][HTML] Duration of COVID-19 mRNA vaccine effectiveness against severe disease
…, A Al Khal, R Bertollini, MH Al-Thani, E Farag… - Vaccines, 2022 - mdpi.com
Waning immunity following administration of mRNA-based COVID-19 vaccines remains a
concern for many health systems. We undertook a study to determine if recent reports of …
concern for many health systems. We undertook a study to determine if recent reports of …
[HTML][HTML] Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar
There is limited seroepidemiological evidence on the magnitude and long-term durability of
antibody titers of mRNA and non-mRNA vaccines in the Qatari population. This study was …
antibody titers of mRNA and non-mRNA vaccines in the Qatari population. This study was …
[HTML][HTML] Narrative Review on Endemic Communicable Diseases in Africa: Mortality and Morbidity Trends, Impacts on Families, and the Way Forward
…, A Saeed, D Bansal, H Al-Romaihi, E Farag* - Qatar Journal of Public …, 2024 - qscience.com
African nations have experienced various environmental and anthropological changes,
including climate change, natural disasters, food safety issues, and increased industrial waste. …
including climate change, natural disasters, food safety issues, and increased industrial waste. …
[HTML][HTML] Assessing the Variation in COVID-19 Severity Among the Different Nationalities Living in Qatar
Background Coronavirus disease (COVID-19) is a highly infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it has resulted in a global …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it has resulted in a global …
[HTML][HTML] HIV case reporting and HIV treatment outcomes in Qatar
E Farag, I Bozicevic, AI Tartour, H Nasreldin… - Frontiers in Public …, 2023 - frontiersin.org
Aim The aim of the paper is to provide an overview of available HIV case reporting and
treatment data for in Qatar for the period 2015–2020. Methods HIV case reporting data were …
treatment data for in Qatar for the period 2015–2020. Methods HIV case reporting data were …
Dynamics of anti-S IgG antibodies titers after the second dose of COVID 19 mRNA and non-mRNA vaccines in the manual and craft worker population of Qatar
Background There is limited seroepidemiological evidence on the magnitude and long-term
durability of antibody titers of mRNA and non-mRNA vaccines in the Qatari population. This …
durability of antibody titers of mRNA and non-mRNA vaccines in the Qatari population. This …
The Disability Price Tag of Raising a Neurodivergent Child in Qatar
S Shaban - 2022 - search.proquest.com
… Elmobashar Abu Baker Abdo Farag for his invaluable introductions to key actors within
Qatar’s Ministry of Public Health (MOPH), and to Dr. Mustafa Elamin for providing the connection …
Qatar’s Ministry of Public Health (MOPH), and to Dr. Mustafa Elamin for providing the connection …
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …
[CITATION][C] COVID-19 mRNA Vaccine Effectiveness Against Severe Disease
…, A Al Khal, R Bertollini, MH Al Thani, EA Farag
